Presentation ESC 2024 Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial Presenter: Gi-Byoung Nam September 01, 2024
Presentation ESC 2022 Smartphone-based screening for atrial fibrillation (eBRAVE-AF) – A pragmatic siteless digital randomized clinical trial Presenter: Axel Bauer August 28, 2022
Presentation AHA 2017 Clinical Benefit of Minimally-Interrupted Dabigatran versus Uninterrupted Warfarin for Catheter Ablation of Atrial Fibrillation: A Prospective Randomized Multicenter Trial Presenter: Akihiko Nogami November 13, 2017